Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 39

1.

Overexpression of WISP-1 down-regulated motility and invasion of lung cancer cells through inhibition of Rac activation.

Soon LL, Yie TA, Shvarts A, Levine AJ, Su F, Tchou-Wong KM.

J Biol Chem. 2003 Mar 28;278(13):11465-70. Epub 2003 Jan 15.

2.

Molecular interpretation of ERK signal duration by immediate early gene products.

Murphy LO, Smith S, Chen RH, Fingar DC, Blenis J.

Nat Cell Biol. 2002 Aug;4(8):556-64.

PMID:
12134156
3.

WISP3 is a novel tumor suppressor gene of inflammatory breast cancer.

Kleer CG, Zhang Y, Pan Q, van Golen KL, Wu ZF, Livant D, Merajver SD.

Oncogene. 2002 May 9;21(20):3172-80.

4.

Insulin-like growth factors and cancer.

Fürstenberger G, Senn HJ.

Lancet Oncol. 2002 May;3(5):298-302. Review.

PMID:
12067807
5.

The role of mitogen-activated protein (MAP) kinase in breast cancer.

Santen RJ, Song RX, McPherson R, Kumar R, Adam L, Jeng MH, Yue W.

J Steroid Biochem Mol Biol. 2002 Feb;80(2):239-56. Review.

PMID:
11897507
6.
7.

Spatiotemporal regulation of the p42/p44 MAPK pathway.

Volmat V, Pouysségur J.

Biol Cell. 2001 Sep;93(1-2):71-9. Review. No abstract available.

PMID:
11730325
8.

The nucleus, a site for signal termination by sequestration and inactivation of p42/p44 MAP kinases.

Volmat V, Camps M, Arkinstall S, Pouysségur J, Lenormand P.

J Cell Sci. 2001 Oct;114(Pt 19):3433-43.

9.

Cyr61, a member of CCN family, is a tumor suppressor in non-small cell lung cancer.

Tong X, Xie D, O'Kelly J, Miller CW, Muller-Tidow C, Koeffler HP.

J Biol Chem. 2001 Dec 14;276(50):47709-14. Epub 2001 Oct 11.

12.
13.

The interaction of insulin-like growth factor-I with the N-terminal domain of IGFBP-5.

Zesławski W, Beisel HG, Kamionka M, Kalus W, Engh RA, Huber R, Lang K, Holak TA.

EMBO J. 2001 Jul 16;20(14):3638-44.

14.
15.
16.

Plasma insulin-like growth factor (IGF) I, IGF-binding protein 3, and mammographic density.

Byrne C, Colditz GA, Willett WC, Speizer FE, Pollak M, Hankinson SE.

Cancer Res. 2000 Jul 15;60(14):3744-8.

17.

Function of the IGF-I receptor in breast cancer.

Surmacz E.

J Mammary Gland Biol Neoplasia. 2000 Jan;5(1):95-105. Review.

PMID:
10791772
18.

IGF-I: an essential factor in terminal end bud formation and ductal morphogenesis.

Kleinberg DL, Feldman M, Ruan W.

J Mammary Gland Biol Neoplasia. 2000 Jan;5(1):7-17. Review.

PMID:
10791764
19.

The IGF-I receptor in cancer research.

Baserga R.

Exp Cell Res. 1999 Nov 25;253(1):1-6. Review.

PMID:
10579905

Supplemental Content

Support Center